Testing effectiveness (Phase 2)Study completedNCT06409130
What this trial is testing
Effects of NNC0194-0499, Cagrilintide, and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
Who this might be right for
Alcohol-related Liver Disease
Novo Nordisk A/S 270